Stocks Health care LTGO
Health careLatigo Biotherapeutics, Inc. (LTGO)
At June 30, 2026 it held $55M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on September 3, 2026.
What Latigo Biotherapeutics, Inc. does
Latigo Biotherapeutics, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations).
Latest SEC filings
What Latigo Biotherapeutics, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 3, 2026Quarterly report 10-Q · period to June 30, 2026
- September 3, 2026
- August 18, 2026Passive stake (5% or more) SCHEDULE 13G
- August 17, 2026Activist stake (5% or more) SCHEDULE 13D
- August 17, 2026Passive stake (5% or more) SCHEDULE 13G
- August 13, 2026Passive stake (5% or more) SCHEDULE 13G
- August 10, 2026
- August 10, 2026
- August 7, 2026
- August 6, 2026Form S-1MEF filing S-1MEF
Questions about LTGO
What does Latigo Biotherapeutics, Inc. do?
Latigo Biotherapeutics, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations).
When did Latigo Biotherapeutics, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on September 3, 2026. It covers the period to June 30, 2026.
Similar companies
Follow LTGO
Get an email when Latigo Biotherapeutics, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow LTGO: get an email when it filesWhere the numbers come from
Financial figures are the values Latigo Biotherapeutics, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.